Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection

Eradication of HIV infection will require the identification of all cellular reservoirs that harbor latent infection. Despite low or lack of CD4 receptor expression on Vδ2 T cells, infection of these cells has previously been reported. We found that upregulation of the CD4 receptor may render primary Vδ2 cells target for HIV infection in vitro and we propose that HIV-induced immune activation may allow infection of γδ T cells in vivo. We assessed the presence of latent HIV infection by measurements of DNA and outgrowth assays within Vδ2 cells in 18 aviremic patients on long-standing antiretroviral therapy. In 14 patients we recovered latent but replication-competent HIV from highly purified Vδ2 cells demonstrating that peripheral Vδ2 T cells are a previously unrecognized reservoir in which latent HIV infection is unexpectedly frequent.

[1]  Nancie M Archin,et al.  Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies. , 2015, The Journal of infectious diseases.

[2]  D. Margolis,et al.  Quantitation of Replication-Competent HIV-1 in Populations of Resting CD4+ T Cells , 2014, Journal of Virology.

[3]  H. Hatano,et al.  Occurrence of etravirine/rilpivirine-specific resistance mutations selected by efavirenz and nevirapine in Kenyan patients with non-B HIV-1 subtypes failing antiretroviral therapy , 2014, AIDS.

[4]  C. Johnson,et al.  Effects of a Range-Expanding Sea Urchin on Behaviour of Commercially Fished Abalone , 2013, PLoS ONE.

[5]  Jeffrey N. Martin,et al.  Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers , 2013, AIDS.

[6]  Douglas D. Richman,et al.  Highly Precise Measurement of HIV DNA by Droplet Digital PCR , 2013, PloS one.

[7]  R. Siliciano,et al.  Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies , 2013, PLoS pathogens.

[8]  H. Jomaa,et al.  Primary MHC-Class II+ Cells Are Necessary To Promote Resting Vδ2 Cell Expansion in Response to (E)-4-Hydroxy-3-Methyl-But-2-Enyl-Pyrophosphate and Isopentenyl Pyrophosphate , 2012, The Journal of Immunology.

[9]  A. Perelson,et al.  Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection , 2012, Proceedings of the National Academy of Sciences.

[10]  Haishan Li,et al.  HIV envelope-mediated, CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDS. , 2011, Blood.

[11]  Zheng W. Chen Immune biology of Ag-specific γδ T cells in infections , 2011, Cellular and Molecular Life Sciences.

[12]  Guido Ferrari,et al.  Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy , 2011, PloS one.

[13]  D. Kabelitz γδ T-cells: cross-talk between innate and adaptive immunity , 2011, Cellular and Molecular Life Sciences.

[14]  J. Lifson,et al.  Mechanisms underlying γδ T-cell subset perturbations in SIV-infected Asian rhesus macaques. , 2010, Blood.

[15]  N. Romani,et al.  CD56+ human blood dendritic cells effectively promote TH1-type gammadelta T-cell responses. , 2009, Blood.

[16]  M. Bonneville,et al.  Early Triggering of Exclusive IFN-γ Responses of Human Vγ9Vδ2 T Cells by TLR-Activated Myeloid and Plasmacytoid Dendritic Cells1 , 2009, The Journal of Immunology.

[17]  S. Bernacchi,et al.  Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors , 2009, Microbiology and Molecular Biology Reviews.

[18]  Jean-Saville Cummings,et al.  Impacts of HIV infection on Vγ2Vδ2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDS , 2008, Journal of leukocyte biology.

[19]  J. Coffin,et al.  Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells , 2008, AIDS.

[20]  M. Bonneville,et al.  Potentiation of Antigen-Stimulated Vγ9Vδ2 T Cell Cytokine Production by Immature Dendritic Cells (DC) and Reciprocal Effect on DC Maturation1 , 2006, The Journal of Immunology.

[21]  R. Redfield,et al.  Association between longer duration of HIV-suppressive therapy and partial recovery of the V gamma 2 T cell receptor repertoire. , 2004, The Journal of infectious diseases.

[22]  F. Poccia,et al.  Differentiation of Effector/Memory Vδ2 T Cells and Migratory Routes in Lymph Nodes or Inflammatory Sites , 2003, The Journal of experimental medicine.

[23]  R. Siliciano,et al.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells , 2003, Nature Medicine.

[24]  C. Leen,et al.  Phenotypic analysis of peripheral blood gammadelta T lymphocytes and their targeting by human immunodeficiency virus type 1 in vivo. , 2003, Virology.

[25]  M. Malim,et al.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein , 2002, Nature.

[26]  M. Goldman,et al.  Human γδ T Cells Induce Dendritic Cell Maturation , 2002 .

[27]  J. Wiesner,et al.  Identification of (E)‐4‐hydroxy‐3‐methyl‐but‐2‐enyl pyrophosphate as a major activator for human γδ T cells in Escherichia coli , 2001 .

[28]  H. Lichtenthaler,et al.  Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. , 1999, Science.

[29]  F. Poccia,et al.  Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. , 1999, The Journal of infectious diseases.

[30]  J. Lisziewicz,et al.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.

[31]  D. Richman,et al.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.

[32]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[33]  F. Poccia,et al.  Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons. , 1996, Journal of immunology.

[34]  S. Bartz,et al.  γδ T lymphocyte responses to HIV , 1996 .

[35]  B. Bloom,et al.  Natural and synthetic non-peptide antigens recognized by human γδ T cells , 1995, Nature.

[36]  A. Garzino-Demo,et al.  Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection , 1995, The Journal of experimental medicine.

[37]  Y. Tanaka,et al.  Nonpeptide ligands for human gamma delta T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  T. Miyawaki,et al.  Differential expression of CD45RO (UCHL1) and its functional relevance in two subpopulations of circulating TCR-gamma/delta+ lymphocytes , 1990, The Journal of experimental medicine.

[39]  M. Stevenson,et al.  HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.

[40]  C. Katlama,et al.  T cell receptor gamma/delta+ lymphocyte subsets during HIV infection. , 1989, Clinical and experimental immunology.

[41]  M. Bonneville,et al.  Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation. , 2006, Journal of immunology.

[42]  R. Siliciano,et al.  Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. , 2005, Methods in molecular biology.

[43]  M. Goldman,et al.  Human gamma delta T cells induce dendritic cell maturation. , 2002, Clinical immunology.

[44]  J. Wiesner,et al.  Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gammadelta T cells in Escherichia coli. , 2001, FEBS letters.

[45]  A. Hayday [gamma][delta] cells: a right time and a right place for a conserved third way of protection. , 2000, Annual review of immunology.

[46]  H. Kiyono,et al.  Functional γδ T-lymphocyte Defect Associated with Human Immunodeficiency Virus Infections , 1997, Molecular medicine.

[47]  Y. Tanaka,et al.  Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. , 1995, Nature.